"I hope that this great player comes back to the court as soon as possible," Lin said referring to Lee, according to China's official Xinhua news agency.
"Not only does Malaysia need him, but the whole badminton world needs him."
Lee, currently the world number one, has been suspended from competition after testing positive for the banned anti-inflammatory dexamethasone, and could be barred for up to two years.
Lee said the turn of events felt like a "bad dream", adding there was "no way" he could have taken the drug outside the auspices of Malaysia's National Sports Institute.
Lin and Lee have long been rivals despite Lin's frequent absences due to repeated injuries. The two players have faced off 33 times since 2004, according to Xinhua.
"I hope Lee's scandal isn't real," Lin was quoted as saying on Wednesday. "I still want to see the Lin-Lee rivalry, those games always bring great fun for the fans.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
